ProBioGen signs commercial licence agreement with AstraZeneca for using GlymaxX technology
Following evaluation of the technology under a research license, AstraZeneca will now continue to use GlymaxX and will integrate…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.